Amid US funding freezes, the future of clinics and healthcare services around the world is unclear, putting decades of progress in the global fight against HIV at risk.
The state's decriminalisation rollback has led to thousands of arrests feeding disruptive cycles of detention and release with no improvements in access to housing, healthcare and other forms of support.
Trump has nominated Carter, a former right-wing journalist, to lead a tough-on-crime agenda at the Office of National Drug Control Policy, despite a lack of relevant experience.
The executive director of the Drug Policy Alliance explains how US funding cuts will affect addiction treatment, overdose prevention, and other harm reduction services.
Criminalised supply networks are harmful, but designating them as terrorist groups is an ill-fitting response that will disproportionately harm vulnerabilised people.
Eschliman et al. show that stigmatising terminology in NIDA-funded grant abstracts has dropped by over half since 2013 and provide guidance for further elimination.
Zolopa et al. identify predictive factors of overdose requiring an emergency response at SIS in Montréal, including gender identity, age, housing status, and frequency and nature of use.
This webinar aims to present updates on developments in decriminalisation around the world, the backlash in Oregon (US), British Columbia (Canada) and Porto (Portugal), and to discuss their impacts on drug policy and advocacy in Asia.
Services have closed without warning, leaving people without access to sterile syringes and opioid agonist treatment, critical to stem HIV incidence and mortality.
